What type of study is this?

This is a Observational study (also classified as: Meta-Analysis).

August 26, 2025Open Access

Multi-Trait Polygenic Scores for COPD and COPD Exacerbations Implicate Druggable Proteins

View Full Paper

Ask AI

Bookmark

Authors

Prospective cohorts reveal multi-trait polygenic scores improve COPD risk predictions, suggesting druggable proteins for therapy.

The multi-trait polygenic score framework improved COPD and exacerbation risk prediction, indicating its potential in therapy.
A significant association was noted with COPD status, showing an odds ratio of 1.58 and a beta of 0.21 for exacerbation frequency.
An observational analysis across multiple cohorts identified 73 proteins linked to the polygenic scores, with 25 being druggable targets.
Results highlight the importance of integrating genetic and proteomic data for advancing precision medicine approaches in COPD.

Zhang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

August 26, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Prospective cohorts reveal multi-trait polygenic scores improve COPD risk predictions, suggesting druggable proteins for therapy.

The multi-trait polygenic score framework improved COPD and exacerbation risk prediction, indicating its potential in therapy.
A significant association was noted with COPD status, showing an odds ratio of 1.58 and a beta of 0.21 for exacerbation frequency.
An observational analysis across multiple cohorts identified 73 proteins linked to the polygenic scores, with 25 being druggable targets.
Results highlight the importance of integrating genetic and proteomic data for advancing precision medicine approaches in COPD.

Zhang et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark